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 Decellularized tissues composed of extracellular matrix are commonly used for tissue 
transplantations but this method has many limitations. An alternative approach is to create an 
extracellular matrix by seeding degradable foams with cells, culturing these foams to allow 
extracellular matrix to be secreted from the cells, then washing away the degradable foam to 
collect the material that is produced. This study was interested in comparing decellularized 
skeletal muscle tissue to an engineered biomaterial that was seeded with skeletal muscle 
myoblast cells. Collagen content of decellularized tissue and engineered biomaterial were 
quantified using a hydroxyproline assay to compare the two samples. The engineered biomaterial 
collagen content value was significantly lower than the decellularized muscle tissue value. 
However, results did suggest that the engineered biomaterial is able to support the growth of 




Tissue transplantation is severely limited by the problems of donor shortage and immune 
rejection. An alternative is to grow replacement tissues outside of the body using the patient’s 
own cells. The common approach of tissue engineering has been to create tissue mimics by 
growing human cells on degradable polymeric foams, also known as scaffolds. These 3-D 
biomaterial scaffolds help provide a temporary support for the cells during growth in culture [4]. 
Unfortunately, studies show that once implanted these scaffolds can evoke a foreign body 
response by the immune system due to the synthetic polymers and other biomaterials that they 
are composed of. Therefore, non- synthetic alternatives are needed.  
One alternative that has seen clinical success is creating implantable materials from the 
tissues of non-human animals.  These biological materials are composed of extracellular matrix 
(ECM) which is by definition, nature’s ideal biological scaffold material. The ECM is 
specifically synthesized by the resident cells of each tissue and provides a supportive medium for 
blood or lymphatic vessels and nerves [3]. The multi-molecular nature of such cell derived 
constructs gives these naturally derived biomaterials a level of complexity and regenerative 
ability not observed with synthetic materials [1,2]. This harvesting process known as 
decellularization is useful in a number of biomedical applications such as understanding the 
physicochemical properties of ECM and providing a tissue specific scaffold for engineering 
functional tissues [11]. 
Yet the harvest of “fully formed” animal tissues, generally limited to skin and intestine, 
provides only limited opportunities to engineer the material’s properties to meet a particular 
medical need. Fundamentally, the harvest of animal tissue is not an engineering approach and 
opportunities for significant innovation still exist.  
Towards this end, a method to isolate the extracellular matrix in bulk from populations of 
cells grown in culture has been created [8.]. The strategy requires developing platforms to collect 
the ECM that the cells secrete. Sacrificial, open celled foams are utilized to concentrate and 
capture the ECM that is secreted by cells under selected growth conditions in vitro. Following a 
culture period, the underlying foam is removed by dissolution with a solvent, and the 
accumulated ECM is collected.  The method provides a reliable means to engineer a variety of 
materials by selecting the cell type and the growth conditions to produce carefully engineered 
regenerative biomaterials with unique structures and compositions.  
This study is interested in using this approach to create a material intended for the repair of 
damaged skeletal muscle tissue. The specific goal of the project is to use the sacrificial 
scaffolding approach with human muscle cells and determine the characteristics of the material 
that is produced. These characteristics will be compared to decellularized muscle samples to 
evaluate the effectiveness of this new method.  
In order to determine the characteristics of the extracellular matrix, the collagen content of 
the material is often found. Collagen is one of the more important structural proteins in the body 
being of particular importance in connective tissues by providing their durability. Specifically in 
skeletal muscle ECM, it accounts for 1-10% of muscle mass dry weight [12]. Knowledge of at 
least the amount of collagen in a particular tissue is essential for the complete understanding of 
the structural and mechanical properties of that tissue. The amino acid hydroxyproline is a major 
component of collagen and few other proteins contain this amino acid. For most tissues, it is 
possible to obtain a reasonable first approximation of collagen content by utilizing a biochemical 
assay for hydroxyproline [10].  
 
2. Methods and Materials 
2.1 Sacrificial Foam Preparation 
 
The sacrificial foam scaffolds were fabricated from medical grade polyurethane (Tecoflex SG-
80, Thermedics) using a phase inversion process [7.]  Briefly, SG80-A polyurethane (PU) pellets 
were dissolved in the solvent dimethylacedamide (DMAC) (10% w/v) overnight at 60C. Next, 
approximately 10 g of sugar and 200 uL DI were mixed and added to molds to create a sugar-
filled mold (Figure 1a). Excess sugar/water mixture was carefully scraped off of molds. (Figure 
1b). Sugar-filled molds were heated at 75°C until dry (at least 20 minutes). Once dry, molds 
were removed and transferred to fume hood. 2 ml SG80-A/DMAC solution was added to each 
mold. The main objective of this part is to apply as much solution to the mold without applying a 
greater volume than the mold’s volume [Figure 1c]. The sugar mold should appear saturated. The 
molds were then carefully placed in a container filled with DI until completely submerged for 24 
hours, which both precipitated the PU solution and dissolved the sugar scaffold[Figure 1d]. The 
polymer scaffolds were removed from the molds and placed in a separate DI bath and were 
stirred for 24 hours.  The polyurethane foams contained a network of pores consistent with the 
prior location of the sugar scaffold. 
2.2 Cell Seeding and Culturing 
 
PU foams were coated overnight in a fibronectin solution (20ug/ml) to encourage attachment 
of cells. Skeletal cells (L6,ATTCC, Manasas VA) were expanded to the necessary number in 




Fig. 1. Sugar/water mixture being added to molds (A). Excess sugar/water mixture carefully being removed (B) 
After drying, adding SG280-A/DMAC solution to each mold (C) then carefully submerging molds into DI (D).  
 
million cells/ sample). All samples were cultured for four weeks and maintained in a growth 
medium consisting of DMEM/F12 supplemented with 10% fetal bovine serum (FBS), 
gentamicin, and 1mM ascorbic acid (Sigma, St. Louis, MO). Growth media was changed every 
2-3 days. Samples were stimulated with TF-Beta1(4ng/ml) to stimulate ECM production. 
2.3 Material Extraction 
At the end of the culture period, the sacrificial polyurethane foams were removed. Samples 
were rinsed in phosphate buffered saline to remove residual media, and incubated in DMAC for 
72 hours at 37 degree Celsius. The solvent was exchanged four times during the seventy-two 
hour incubation period, twice on the first day and then daily thereafter. Following DMAC 
incubation, the remaining material was rinsed three times in DI water, frozen, and lyophilized.  
2.4 Animals and decellularization of skeletal muscle 
 
 Rat quadriceps muscles were dissected from rats to obtain native muscle tissue for 
comparison of data. Following dissection, right quadriceps muscles were decellularized using a 
previously published protocol [3]. Samples were submersed in 1% sodium dodecyl sulphate 
(SDS) in distilled water and solution was exchanged every 48 h for one week. At least 4ml of 
SDS solution was used for each sample. At the end of the decellularization procedure, the 
muscles were thoroughly washed by means of three incubations lasting 30 min in PBS. 
Decellularized muscles underwent a rinsing period in distilled water for one week. (Solution was 
exchanged every 24 h.)  
2.5 Material Testing 
 Samples were prepared for scanning electron microscopy (SEM) to analyze the topography 
and physical characteristics of material collected. Samples were imaged with assistance from the 
University of Arkansas Nanotechnology Imaging Facility. 
Collagen was quantified in engineered tissue and native rat muscle using a hydroxyproline 
assay. The method described is a modification of an assay first introduced by Stegemann and 
Sterr [9]. Sample hydrolysis was performed by combining hydrochloric acid with engineered 
tissue in a 1mL: 2mg ratio and rat muscle in 1mL:1mg ratio and hydrolyzing for 16-20 hours at -
20°C. Samples were diluted with dH20 (40uL sample in 160uL H20). Hydroxyproline buffer 
was made by combining 25 g citric acid monohydrate in 600mL dH20, 6 mL glacial acetic acid, 
36 g sodium acetate, 17 g sodium hydroxide, 150 1-propanol, and 750 uL toluene. 
Hydroxyproline standard was created by dissolving 10.1 mg hydroxyproline in 100mL 
hydroxyproline buffer (101mg/uL). Standard was diluted 3:2 ratio across a 96 well plate. 125uL 
of each sample was added into triplicate on the 96 well plate. A buffer was created to oxidize the 
hydroxyproline using a solution made of 122.5 mg Chloramine–T dissolved in 3.5 mL 1-
proponal and 28mL hydroxyproline buffer. 100ul of buffer was added to samples. Plate was 
covered and incubated for 20 minutes at room temperature. Next a buffer containing 1.05g 
40dimethylamniobenzaldehyde in 5mL proponal and 1.85 mL perchloric acid was created for 
staining hydroxyproline. 100ul of this buffer was added to each sample and standard dilution 
then plate was covered and incubated at 65°C for 25 minutes. Plates were read at 570nm 
absorbency. All samples were corrected for volume of sample loaded and multiplied by volume 
of HCL used in hydrolysis to determine ug hydroxyproline per mg of tissue. Statistical analysis 
(t-test) was performed to compare collagen content values of two groups. A 0.05 level of 









3.1 Visual Observations 
  
 Thin sectioning of engineered material revealed a porous network similar to ECM 
material and residual cellular fragments as shown in Figure 2. These results suggest the 
collection of ECM from muscle fibroblast is viable. 
3.2 Collagen content 
 
After performing hydroxyproline assay, the engineered biomaterial (n=4) was determined 
to have a 1.55±.44% collagen content and the decellularized muscle (n=4) had a 8.39±3.51% 
collagen content. Collagen content was calculated as function of hydroxyproline, a major amino 
 
Fig. 2. (A) ECM biomaterial prepared using muscle myoblast cells (L6 cells) shown in bulk form. (B, C, D) 
Magnified view to show surface and texture. 
B
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acid in collagen, and the results are shown in Figure 3. The difference between engineered 




The biomaterial produced displayed 
encouraging results with a porous network common to 
an extracellular matrix. However, the physical 
structure of the material produced didn’t reveal the 
same structure of skeletal muscle ECM [12]. Due to 
the components of skeletal muscle tissue, its ECM 
tends to have a structure revealing a honeycomb when 
a cross section is analyzed. The engineered 
biomaterial tended to have a structure similar to the 
sacrificial foam it was originally seeded on. It would 
be beneficial to create foams similar to skeletal muscle 
tissues because the material grown according to the 
process in this study tends to favor the foam it is seeded on.  
Because the collagen content of the engineered tissue samples is significantly lower than 
the decellularized tissue samples, studies can be performed in the future to encourage growth of 
collagen in the engineered samples. Specifically, transforming growth factor-β (TGF- β) is a 
hormonally active polypeptide that controls cell growth and differentiation. TGF- β has been 
shown to induce fibroblasts to produce increased amount of collagen and fibronectin [13]. 
Therefore, it would be beneficial to conduct a study manipulating the amount of TGF- β seeded 




Figure 3. Hydroxyproline assay was performed 
on engineered muscle matrix (EMM) and 
decellularized muscle (DSM). Results reveal 
collagen content as a percent of total weight 
(mean±SD, n=4)  
Another means of promoting collagen growth would be to seed the foams with more 
cells. This study seeded the cells at a density of 2 million cells/cm3 so it would be advantageous 
to increase this amount to see if growth is encouraged or if there appears to be a density limit for 
foams. Correspondingly, growth might increase with increased cell culturing time.  
Not addressed in this study is the foreign body response to this cell-derived ECM. The host 
response to biologic scaffold materials composed of ECM involves both the innate and acquired 
immune system, and the response is affected by device specific variables including the intended 
clinical application, the source of the raw material/tissue from which the ECM is harvested, and 
the processing steps involved in manufacturing [14]. However, a cell derived ECM is the ideal 
scaffold because it is specifically synthesized by the resident cells of each tissue and is likely 
biocompatible since host cells produce their own matrix [3]. The cytotoxicity of the material still 
needs to be addressed before it can be fully reproduced in the future. 
 
5.0 Conclusion 
The results of this study have revealed that there is an approach to creating a cell derived 
extracellular matrix that with further research can be compared to decellularized muscle. 
Because traditional extracellular matrix scaffolds induce the foreign body response and are 
limited by donor organs, the ability to create such a material would be beneficial for a variety of 
medical treatments requiring muscle growth.  
References 
 
[1]Hoganson, D. M., Owens, G. E., O’Doherty, E. M., Bowley, C. M., Goldman, S. M., Harilal, 
D. O., et al. (2010). Preserved extracellular matrix components and retained biological activity in 
decellularized porcine mesothelium. Biomaterials, 31(27), 6934-6940.  
[2]Kim, M. S., Ahn, H. H., Shin, Y. N., Cho, M. H., Khang, G., & Lee, H. B. (2007). An in vivo 
study of the host tissue response to subcutaneous implantation of PLGA- and/or porcine small 
intestinal submucosa-based scaffolds. Biomaterials, 28(34), 5137-5143.  
[3]Perniconi, B., Costa, A., Aulino, P., Teodori, L., Adamo, S., & Coletti, D. (2011). The pro-
myogenic environment provided by whole organ scale acellular scaffolds from skeletal muscle. 
Biomaterials, 32(31), 7870-7882.  
[4]Principles of regenerative medicine (2nd edition)(2010). In Atala A., Lanza R. and Thomson 
J. A. (Eds.), . Saint Louis, MO, USA: Academic Press.  
[5]Stern, M. M., Myers, R. L., Hammam, N., Stern, K. A., Eberli, D., Kritchevsky, S. B., et al. 
(2009). The influence of extracellular matrix derived from skeletal muscle tissue on the 
proliferation and differentiation of myogenic progenitor cells ex vivo. Biomaterials, 30(12), 
2393-2399.  
[6]Valentin, J. E., Turner, N. J., Gilbert, T. W., & Badylak, S. F. (2010). Functional skeletal 
muscle formation with a biologic scaffold. Biomaterials, 31(29), 7475-7484.  
[7]Webb, K., Li, W., Hitchcock, R. W., Smeal, R. M., Gray, S. D., & Tresco, P. A. (2003). 
Comparison of human fibroblast ECM-related gene expression on elastic three-dimensional 
substrates relative to two-dimensional films of the same material. Biomaterials, 24(25), 4681-
4690.  
[8]Wolchok, J. C., & Tresco, P. A. (2010). The isolation of cell derived extracellular matrix 
constructs using sacrificial open-cell foams. Biomaterials, 31(36), 9595-9603.  
[9.] Stegemann, H. and Stalder, K. (1967) Clin. Chim. Acta 18,267 
[10] Edwards, C.A., O’Brien W.D. (1980). Modified Assay for Determination of hydroxyproline 
in a tissue hydrolyzate, Clinica Chimica Acta 104, 161-167. 
[11] Gillies, A.R., Smith L.R., Lieber R.L., Varghese S. (2011). Method for Decelluarizing 
Skeletal Muscle Without Detergents or Proteolytic Enzymes. Tissue Engineering 7(4), 383-389 
[12] Allison RG & Lieber RL. (2011) Structure and Function of the Skeletal Muscle 
Extracellular Matrix. Muscle Nerve, 44(3), 318-331. 
[13] Ignotz RA & Massague J. (1986). Transforming Growth Factor-β Stimulates the Expression 
of Fibronectin and Collagen and Their Incorporation into the Extracellular Matrix. The Journal 
of Biological Chemistry, 261(9), 4337-4345. 
[14] Badylk SF & Gilbert TW (2008). Immune Response to Biologic Scaffold Materials. Semin 
Immunol, 20(2), 109-116. 
 
 
